Skip to product information
1 of 6

40 capsules*5 boxes. Bufei Huoxue Jiaonang for pulmonary heart disease remission period. Traditional Chinese Medicine.

40 capsules*5 boxes. Bufei Huoxue Jiaonang for pulmonary heart disease remission period. Traditional Chinese Medicine.

Regular price $59.99 USD
Regular price Sale price $59.99 USD
Sale Sold out
Shipping calculated at checkout.
Bufei Huoxue Jiaonang
Bu Fei Huo Xue Jiao Nang
Bufeihuoxue Jiaonang
Bufei Huoxue Capsule
Bu Fei Huo Xue Capsule
Bufeihuoxue Capsule

It is used for pulmonary heart disease (remission period) due to deficiency of qi and blood stasis syndrome;symptoms: cough with shortness of breath, or chest tightness, palpitations and shortness of breath, cold limbs,sorness and weakness of waist and knees, cyanosis of the lips, pale tongue, white or dark purple tongue.
Chronic pulmonary heart disease is one of its main treatment diseases, which can improve the patient's heart and lung function, reduce attacks, delay the progression of the disease, and at the same time improve the body's immunity and reduce the number of acute attacks.

Traditional Chinese Medicine Functions
Benefiting qi for activating blood circulation,tonifying lung and reinforcing the kidney.

Milkvetch Root, Red Peony Root, Malaytea Scurfpea Fruit.

Hard capsule, the content is brown fine granules and powder; slightly fragrant, slightly sour and bitter taste.

0.35g*40 capsules/box.

For oral use after meals,4 capsules thrice daily or by medical ordor. It is recommended to take it with warm water for three consecutive months as a course of treatment. It should be noted that during the medication, you should eat lightly, not eat raw or cold food, and keep warm, reduce the irritation to the respiratory tract, and maintain indoor ventilation.

Clinical application of Bufei Huoxue Capsule:

1.The effect of Bufeihuoxue Capsule combined with bronchoalveolar lavage on the lung ventilation function of patients with pneumoconiosis[4]: Bufeihuoxue Capsule combined with bronchoalveolar lavage treatment can improve the clinical symptoms of patients with pneumoconiosis at various stages, improve their ventilation function, and improve patient survival quality.
2.Observation of the clinical efficacy of Bufeihuoxue Capsules on patients with stable chronic obstructive pulmonary disease[3]: Combining the treatment with Bufeihuoxue Capsules on the basis of Western medicine in the stable period of COPD can better relieve the symptoms of patients and prevent acute attacks. Improving the quality of life has good promotion and application value.
3.Treatment of 38 cases of silicosis complicated with chronic obstructive pulmonary disease: Bufeihuoxue Capsule and Asarone Tablets can relieve cough, sputum, chest tightness, wheezing, cyanosis and dyspnea in patients with silicosis complicated with chronic obstructive disease. The medication is convenient, safe, and has no adverse effects. reaction.
4. Study on the efficacy of the method of invigorating the lung, promoting blood circulation and removing blood stasis to prevent the acute exacerbation of chronic obstructive pulmonary disease: Chinese medicine for invigorating the lung, promoting blood circulation and removing blood stasis can effectively reduce the number of acute exacerbations of COPD and improve clinical symptoms.
5. Acupoint application combined with Bufei Huoxue Capsule to prevent and treat 160 cases of chronic bronchitis: Acupoint application combined with Bufei Huoxue Capsule orally taken has a good effect on the prevention and treatment of chronic bronchitis.

Occasionally dry mouth.


1.Hypersensitivity to this product should stop using,allergic constitution with caution.
2.Do not use this product if the property changed.
3.Keep out of reach of children.
4.If you are using other drugs, please consult your doctor before using this product.

If use with the other drugs at the same time may occur drug interactions,details please consult your physician or pharmacist.

Pharmacology and Toxicology
Pharmacological tests show that this product can reduce the red blood cell, white blood cell, platelet count and hemoglobin of FeCl3-induced pulmonary heart disease model rabbits, reduce whole blood viscosity, plasma viscosity, hematocrit, and have a certain effect on reducing the rate of pulmonary P wave abnormality. It can reduce the partial pressure of carbon dioxide in the blood gas and increase the partial pressure of oxygen and oxygen saturation. It can promote the production of mouse serum hemolysin and splenic hemolytic plaque forming cells, increase the cardiac output and coronary blood flow of anesthetized dogs, and have a certain effect on the total peripheral resistance of blood vessels, coronary resistance, and myocardial oxygen consumption. , Oxygen consumption index has a certain reduction effect. It can prolong the incubation period of cough in mice induced by ammonia water, reduce the number of coughs, and have a certain effect on prolonging the incubation period of asthma in guinea pigs with histamine-induced asthma.

Hermetically sealed,keep in cool and dry places.

24 months.

Stage Food and Drug Administration Approval number:Z20030063.


Tips: Please read the directions for use in retail or directed by physician.
Part of the goods frequent replacement of packaging, such as goods and pictures are not exactly the same, please refer to the goods you receive.

General Cautions
Keep away from animals and children.This product has not been evaluated by the FDA. It is not intended to diagnose, treat, cure, or prevent any disease.We highly recommend that you consult with a Traditional Chinese Medical practitioner or physician before taking any products or if you have any questions regarding your health.
View full details